Development of Clinical Database of Individuals With Smith-Magenis Syndrome and Sleep Disturbances
Purpose
This database will be used to better understand the sleep problems of people with SMS. This clinical database will be a part of a larger Smith-Magenis Patient Registry used to create an awareness campaign around SMS and the sleep disturbances that are characteristic of the disorder.
Condition
- Sleep Disturbances in Smith-Magenis Syndrome
Eligibility
- Eligible Ages
- Between 3 Years and 65 Years
- Eligible Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- Parent or legal guardian of individual with Smith-Magenis Syndrome
Exclusion Criteria
- Not legal guardian of individual with SMS
Study Design
- Phase
- Study Type
- Observational
- Observational Model
- Case-Only
- Time Perspective
- Cross-Sectional
Recruiting Locations
Vanda Pharmaceuticals
Washington D.C. 4140963, District of Columbia 4138106 20037
Washington D.C. 4140963, District of Columbia 4138106 20037
Contact:
Vanda Pharmaceuticals
202-734-3400
Vanda Pharmaceuticals
202-734-3400
More Details
- Status
- Recruiting
- Sponsor
- Vanda Pharmaceuticals